The Wall Street titan issued some of his bluntest public criticism of the White House’s trade policy to date on Trump’s 100 ...

The new facility will produce biologic drugs and Keytruda, becoming Merck’s first in-house US site to make the blockbuster cancer treatment, the company said.

Having backed Trump for reasons that for many were likely purely commercial, the tech bros are discovering he is not good for ...